Mucosal biofilm communities in the human intestinal tract

Advances in Applied Microbiology

Volumn 75, Issue , 2011, Pages 111-143

  Macfarlane, Sandra ^a   Bahrami, Bahram ^a   Macfarlane, George T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Biofilm; Human intestinal tract; Inflammatory bowel disease; Intestinal bacteria; Mucosal communities

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; METRONIDAZOLE; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; TETRACYCLINE;

ANTIBIOTIC THERAPY; BACTEROIDETES; BIFIDOBACTERIACEAE; BIOFILM; BOOK; CHRONIC DISEASE; CLOSTRIDIUM; CROHN DISEASE; ECOSYSTEM; ENTERITIS; EPITHELIUM; ESCHERICHIA COLI; ESOPHAGUS; FECES; GASTRITIS; GASTROINTESTINAL TRACT; HOST PARASITE INTERACTION; HUMAN; IMMUNE STATUS; IMMUNE SYSTEM; INTESTINE FLORA; INTESTINE MUCOSA; LARGE INTESTINE; MICROFLORA; MOUTH CAVITY; NONHUMAN; SQUAMOUS CELL CARCINOMA; STREPTOCOCCUS; ULCERATIVE COLITIS; BACTERIUM; INTESTINE; MICROBIOLOGY; MUCOSA;

BACTERIA (MICROORGANISMS);

BACTERIA; BIOFILMS; GASTROINTESTINAL TRACT; HUMANS; INTESTINES; MUCOUS MEMBRANE; PROBIOTICS;

EID: 79960923900     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387046-9.00005-0     Document Type: Chapter

References (142)

1. Ahmed S., Macfarlane G.T., Fite A., McBain A.J., Gilbert P., Macfarlane S. Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl. Environ. Microbiol. 2007, 73:7435-7442.
2. Allen A. Sructure and function of gastrointestinal mucus. Physiology of the Gastrointestinal Tract 1981, 617-639. Raven Press, New York. L.R. Johnston (Ed.).
3. Anwar H., Dasgupta M.K., Costerton J.W. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob. Agents Chemother. 1990, 34:2043-2046.
4. Bamba T., Matsuda H., Endo M., Fujiyama Y. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J. Gastroenterol. 1995, 30:45-47.
5. Baumgart M., Dogan B., Rishniw M., Weitzman C., Bosworth B., Yantiss R., Orsi R.H., Wiedmann M., McDonough P., Kim S.G., Berg D., Schukken Y., et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive E. coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 2007, 1:403-418.
6. Belenguer A., Duncan S.H., Calder A.G., Holtrop G., Louis P., Lobley G.E., Flint H.J. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl. Environ. Microbiol. 2006, 72:3593-3599.
7. Bibiloni R., Mangold M., Madsen K.L., Fedorak R.N., Tannock G.W. The bacteriology of biopsies differs between newly diagnosed, Crohn's disease and ulcerative colitis patients. J. Med. Microbiol. 2006, 55:1141-1149.
8. Bik E.M., Eckburg P.B., Gill S.R., Nelson K.E., Purdom E.A., Francois F., Perez-Perez G., Blaser M.J., Relman D.A. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. USA 2006, 103:732-737.
9. Blaser M.J., Atherton J.C. Helicobacter pylori persistence: Biology and disease. J. Clin. Invest. 2004, 113:321-333.
10. Bourriaud C., Robins R.J., Martin L., Kozlowski F., Tenailleau E., Cherbut C., Michel C. Lactate is mainly fermented to butyrate by human intestinal microbiota but inter-individual variation is evident. J. Appl. Microbiol. 2005, 99:201-212.
11. Burke D., Axon A. Adhesive E. coli in inflammatory bowel disease and infective diarrhoea. Br. Med. J. 1988, 297:102-104.
12. Chadwick V.S. Etiology of chronic ulcerative colitis and Crohn's disease. The Large Intestine: Physiology, Pathophysiology and Disease 1991, 445-463. Raven Press, New York. S.F. Philips, J.H. Pemberton, R.G. Shorter (Eds.).
13. Cohavy O., Bruckner D., Gordon L.K., Misra R., Wei B., Eggena M.E., Targan S.R., Braun J. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect. Immun. 2000, 68:1542-1548.
14. Corfield A.P., Wagner S.A., Clamp J.R., Kriaris M.S., Hoskins L.C. Mucin degradation in the human colon: Production of sialidase, sialate O-acetylesterase, N-acetylneuraminatelyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect. Immun. 1992, 60:3971-3978.
15. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process- First american cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992, 52:6735-6740.
16. Croucher S.C., Houston A.P., Bayliss C.E., Turner R.J. Bacterial populations associated with different regions of the colon wall. Appl. Environ. Microbiol. 1983, 45:1025-1033.
17. Cummings J.H., Macfarlane G.T., Macfarlane S. Intestinal bacteria and ulcerative colitis. Curr. Issues Intest. Microbiol. 2003, 4:9-20.
18. Darfeuille-Michaud A., Neut C., Barnich N., Lederman E., DiMartino P., Desreumaux P., Gambiez L., Joly B., Cortot A., Colombel J.F. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998, 115:1405-1413.
19. Darfeuille-Michaud A., Boudeau J., Bulios P., Neut C., Glasser A.L., Barnich N., Bringer M.A., Swidsinski A., Beaugerie L., Colombel J.F. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004, 127:412-421.
20. de Hertogh G., Aerssens J., De Hoogt R., Peeters P., Verhasselt P., van Ectors E.N., Vermiere S., Rutgeerts P., Coulie B., Geboes K. Validation of 16S rDNA sequencing in microdissected biopsies from Crohn's disease patients to assess bacterial flora diversity. J. Pathol. 2006, 209:532-539.
21. Dicksved J., Lindberg M., Rosenquist M., Enroth H., Jannson J.K., Engstrand l Molecular characterization of the stomach microbiota in patients with gastric cancer and controls. J. Med. Microbiol. 2009, 58:509-516.
22. Draser B.S., Shiner M., Mcleod G.M. Studies on the intestinal flora. 1. The bacterial flora of the gastrointestinal tract in healthy and achorohydric persons. Gastroenterology 1969, 56:71-79.
23. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefson L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science 2005, 10:1635-1638.
24. Edmiston C.E., Avant G.R., Wilson F.A. Anaerobic bacterial populations on normal and diseased human biopsy tissue obtained at colonoscopy. Appl. Environ. Microbiol. 1982, 43:1173-1181.
25. Ezaki T., Oyaizu H., Yabuuchi E. The anaerobic gram-positive cocci. The Prokaryotes 1991, Vol. II:1878-1892. Springer-Verlag, New York. 2nd edn. A. Balows, H.G. Truper, M. Dworkin, W. Harder, K.H. Schleifer (Eds.).
26. Fakhry S., Manzo N., D'Apuzzo E., Pietrini L., Sorrentini I., Ricca E., De Felice M., Baccigalupi L. Characterization of intestinal bacteria tightly bound to the human ileal epithelium. Res. Microbiol. 2009, 160:817-823.
27. Famularo G., Moretti S., Marcellini S., De Simone C. Stimulation of immunity by probiotics. Probiotics: Therapeutic and Other Beneficial Effects 1997, 133-161. Chapman and Hall, London. R. Fuller (Ed.).
28. Cordoba, Argentina. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria FAO/WHO. http://www.who.int/foodsafety/publications/fsj_management/en/probiotics.pdf.
29. Finegold S.M., Attebery H.R., Sutter V.L. Effect of diet on human fecal flora: Comparison of Japanese and American diets. Am. J. Clin. Nutr. 1974, 27:1456-1469.
30. Fite A., Macfarlane G.T., Cummings J.H., Hopkins M.J., Kong S.C., Furrie E., Macfarlane S. Identification and quantification of mucosal and faecal desulfovibrios using real-time PCR. Gut 2004, 53:523-529.
31. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 2007, 104:13780-13785.
32. Furrie E., Macfarlane S., Kennedy A., Cummings J.H., Walsh S.V., O'Neil D.A., Macfarlane G.T. Synbiotic therapy (Bifidobacterium longum/Synergy 1TM initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut 2005, 54:242-249.
33. Furrie E., Macfarlane S., Cummings J.H., Macfarlane G.T. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut 2004, 53:91-98.
34. Giaffer M.H., Holdsworth C.D., Duerden B.I. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut 1992, 33:646-650.
35. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995, 125:1401-1412.
36. Gibson G.R., Cummings J.H., Macfarlane G.T. Growth and activities of sulphate reducing bacteria in gut contents from healthy subjects and patients with ulcerative colitis. FEMS Microbiol. Ecol. 1991, 86:103-112.
37. Gill H.S., Rutherfurd K.J., Cross M.L., Gopal P.K. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 2001, 74:833-839.
38. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
39. Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzocchi G., Poggioli G., Miglioli M., Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A doubleblind, placebo-controlled trial. Gastroenterology 2000, 119:305-309.
40. Glasser A.L., Boudeau J., Barnich N., Perruchot M.H., Colombel J.F., Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 2001, 69:5529-5537.
41. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: The role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27:104-119.
42. Hartley M.G., Hudson M.J., Swarbrick E.T., Gent A.E., Hellier M.D., Grace R.H. Adhesive and hydrophobic properties of Escherichia coli from the rectal mucosa of patients with ulcerative colitis. Gut 1993, 34:63-67.
43. Hattori M., Taylor T.D. The human intestinal microbiome: A new frontier of human biology. DNA Res. 2009, 16:1-12.
44. Hentges D.J. The anaerobic microflora of the human body. Clin. Infect. Dis. 1993, 16:S175-S180.
45. Hill M.J. The possible role of bacteria in inflammatory bowel disease. Curr. Con. Gastroenterology 1986, 3:10-14.
46. Hold G.L., Pryde S.E., Russell V.J., Furrie E., Flint H.J. Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol. Ecol. 2002, 39:33-39.
47. Holdeman L.V., Cato E.P., Moore W.E.C. Anaerobe Laboratory Manual 1977, Virginia Polytechnic Institute and State University, Blacksburg. 4th edn.
48. Horz H.P., Vianna M.E., Gomes B.P., Conrads G. Evaluation of universal probes and primer sets for assessing total bacterial load in clinical samples: General implications and practical use in endodontic antimicrobial therapy. J. Clin. Microbiol. 2005, 43:5332-5337.
49. Hughes R., Rowland I.R. Nutritional and microbial modulation of carcinogenesis. Gut Flora, Nutrition, Immunity and Health 2003, 208-220. Blackwell Publishing, Oxford, UK. R. Fuller, G. Perdigon (Eds.).
50. Iijima K., Henry E., Moriyama A., Wirz A., Kelman A.W., McColl K.E. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastrooesophageal junction. Gastroenterology 2002, 122:1248-1257.
51. Johansson M.L., Molin G., Jeppsson B., Nobaek S., Ahrne S., Bengmark S. Administration of different Lactobacillus strains in fermented oatmeal soup: In vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl. Environ. Microbiol. 1993, 59:15-20.
52. Kleessen B., Hartmann L., Blaut M. Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br. J. Nutr. 2003, 89:597-606.
53. Kong S.C., Furrie E., Madden J., Kennedy A., Magee E., Macfarlane G.T., Cummings J.H. Comparison of hydrogen sulphide detoxification enzyme mRNA expression in normal and ulcerative colitis rectal mucosae. Gut 2004, 53(S(3)):142.
54. Kong S.C., Furrie E., Macfarlane G.T., Cummings J.H. Regional variation of mRNA of hydrogen sulphide detoxification enzymes in the colon may predispose to ulcerative colitis. Gut 2005, 54(S(2)):352.
55. Kotlowski R., Bernstein C.N., Sepehri S., Krause D.O. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007, 56:669-675.
56. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 1999, 49:8-31.
57. Langlands S.J., Hopkins M.J., Coleman N., Cummings J.H. Prebiotic carbohydrates modify the mucosa-associated microflora of the human large bowel. Gut 2004, 53:1610-1616.
58. Lau W.F., Wong J., Lam K.H., Ong G.B. Oesophageal microbial flora in cancer of the oesophagus. ANZ. J. Surg. 1981, 51:52-55.
59. Lee F.D., Kraszewski A., Gordon J., Howie J.G., McSeveney D., Harland W.A. Intestinal spirochaetosis. Gut 1971, 12:126-133.
60. Lepage P., Seksik P., Sutren M., de la Cochetiere M.F., Jian R., Marteau P., Dore J. Biodiversity of the mucosa-associated microbiota is stable along the digestive tract in healthy individuals and patients with IBD. Inflamm. Bowel Dis. 2005, 11:474-480.
61. Li X.X., Wong G.L.H., To K.F., Wong V.W.S., Lai L.H., Chow D.K.L., Lau J.Y.W., Sung J.J.Y. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS ONE 2009, 4. Article number e7985.
62. Liu L., Xu-Welliver M., Kanugula S., Pegg R.E. Inactivation and degradation of O(6)-Alkylguanine-DNA alkyltransferase after reaction with nitric oxide. Cancer Res. 2002, 62:3037-3043.
63. Loubinoux J., Bronowicji J.P., Pereira I.A.C., Moungenel J.L., Faou A.E. Sulfate-reducing bacteria in human feces and their association with inflammatory diseases. FEMS Microbiol. Ecol. 2002, 40:107-112.
64. Louis P., Flint H.J. Diversity, metabolism and microbial ecology of buyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 2009, 294:1-8.
65. Lu L., Walker A. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am. J. Clin. Nutr. 2001, 73:1124S-1130S.
66. Macfarlane S. Therapeutic use of synbiotics: The use of synbiotics as therapies for maintaining health of the digestive tract. Agro Food Hi Tec. 2006, 17:21-23.
67. Macfarlane G.T., Macfarlane S. Activities of human colonic mucin degrading bacteria on surfaces and in biofilms. Mucin, Methods and Protocols 2000, 71-87. Humana Press, Totowa, NJ. A. Corfield (Ed.).
68. Macfarlane S., Macfarlane G.T. Bacterial diversity in the large intestine. Adv. Appl. Microbiol. 2004, 54:261-289.
69. Macfarlane G.T., Macfarlane S. Models for intestinal fermentation: Association between food components, delivery systems, bioavailabilityand functional interactions in the gut. Curr. Opin. Biotech. 2007, 18:156-162.
70. Macfarlane S., Cummings J.H., Macfarlane G.T. Bacterial colonisation of surfaces in the large intestine. Colonic Microflora, Nutrition and Health 1999, 71-87. Chapman and Hall, London. UK. G.R. Gibson, M. Roberfroid (Eds.).
71. Macfarlane S., Hopkins M.J., Macfarlane G.T. Bacterial growth and metabolism on surfaces in the large intestine. Microb. Ecol. Health Dis. 2000, 2:64-72.
72. Macfarlane S., Furrie E., Cummings J.H., Macfarlane G.T. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin. Infect. Dis. 2004, 38:1690-1699.
73. Macfarlane S., Furrie E., Kennedy A., Cummings J.H., Macfarlane G.T. Mucosal bacteria in ulcerative colitis. Br. J. Nutr. 2005, 93:67-72.
74. Macfarlane S., Woodmansey E.J., Macfarlane G.T. Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl. Environ. Microbiol. 2005, 71:7483-7492.
75. Macfarlane S., Furrie E., Macfarlane G.T., Dillon J.F. Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. Clin. Infect. Dis. 2007, 45:29-38.
76. Macfarlane G.T., Steed H., Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J. Appl. Microbiol. 2008, 104:305-344.
77. Macfarlane G.T., Blackett K.L., Nakayama T., Steed H., Macfarlane S. The gut microbiota in inflammatory bowel disease. Curr. Pharm. Des. 2009, 15:1528-1536.
78. Macfarlane S., Steed H., Macfarlane G.T. Intestinal bacteria and inflammatory bowel disease. Crit. Rev. Clin. Lab. Sci. 2009, 46:25-54.
79. Mannell A., Plant M., Frolich J. The microbiota of the oesophagus. Ann. R. Coll. Surg. Engl. 1983, 65:152-154.
80. Maratka Z. Pathogenesis and aetiology of inflammatory bowel disease. Inflammatory Bowel Disease. Some International Data and Reflections 1986, 29-65. Oxford Medical Publications, Oxford, UK. F.T. de Dombal, J. Myren, I.A.D. Bouchier, G. Watkinson (Eds.).
81. Marshall B.J. Helicobacter pylori. Am. J. Gastroenterol. 1994, 89:S116-S128.
82. Martinez-Medina M., Aldeguer X., Gonzalez-Huix F., Acero D., Garcia-Gil L.J. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm. Bowel Dis. 2006, 12:1136-1145.
83. Martinez-Medina M., Aldeguer X., Lopez-Siles M., Gonzalez-Huix F., Lopez-Oliu C., Dahbi G., Blanco J.E., Blanco J., Garcia-Gil L.J., Darfeuille-Michaud A. Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherant-invasive E. coli (AIEC) in Crohn's disease. Inflamm. Bowel Dis. 2009, 15:872-882.
84. Matsuda H., Fujiyama Y., Andoh A., Ushijima T., Kajinami T., Bamba T. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J. Gastroenterol. Hepatol. 2000, 15:61-68.
85. McWilliam Leitch E.C., Walker A.W., Duncan S.H., Holtrop G., Flint H.J. Selective colonisation of insoluble substrates by human faecal bacteria. Environ. Microbiol. 2006, 9:667-679.
86. Mirvish S.S. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution of cancer of known exposure to NOC. Cancer Lett. 1995, 93:17-48.
87. Monstein H.J., Tiveljung A., Kraft C.H., Borch K., Jonasson J. Profiling of bacterial flora in gastric biopsies from patients with Helicobacter pylori-associated gastritis and histologically normal control individuals by temperature gradient gel electrophoresis and 16S rDNA sequence analysis. J. Med. Microbiol. 2000, 49:817-822.
88. Monteiro E., Fossey J., Shiner M., Drasar B.S., Allison A.C. Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet 1971, 1:249-250.
89. Moore W.E.C., Holdeman L.V. Human fecal flora: The normal flora of 20 Japanese-Hawaiians. Appl. Microbiol. 1974, 27:961-979.
90. Mylonaki M., Rayment N.B., Rampton D.S., Hudspith B.N., Brostoff J. Molecular characterisation of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm. Bowel Dis. 2005, 11:481-487.
91. Nagy K.N., Sonkodi I., Szoke I., Nagy E., Newman H.N. The microflora associated with human oral carcinomas. Oral Oncol. 1998, 34:304-308.
92. Nelson D.P., Mata L.J. Bacterial flora associated with the human gastrointestinal mucosa. Gastroenterology 1970, 58:56-61.
93. Nomura T., Ohkusa T., Okayasu I., Yoshida T., Sakamoto M., Hayashi H., Benno Y., Hirai S., Hojo M., Kobayashi O., Terai T., Miwa H., et al. Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy. Aliment. Pharmacol. Ther. 2005, 21:1017-1027.
94. O'May G.A., Macfarlane G.T. Health claims associated with probiotics. Probiotic Dairy Products 2005, 138-166. Blackwell Publishing, Oxford. A.Y. Tamime (Ed.).
95. Ohkusa T., Sato N., Ogihara T., Morita K., Ogawa M., Okayasu I. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J. Gastroenterol. Hepatol. 2002, 17:849-853.
96. Onderdonk A.B. Role of the intestinal microflora in ulcerative colitis. Human Intestinal Microflora in Health and Disease 1983, 481-493. Academic Press, New York. D.J. Hentges (Ed.).
97. Osias G.L., Bromer M.Q., Thomas R.M., Friedel D., Miller L.S., Suh B., Lorber B., Parkman H.P., Fisher R.S. Esophageal bacteria and Barrett's oesophagus: A preliminary report. Dig. Dis. Sci. 2004, 49:228-236.
98. Ott S.J., Musfeldt M., Wendereroth D.F., Hampe J., Brant O., Fosch U.R., Timmis K.N., Schrieber S. Reduction in diversity of the colonic mucosa associated microflora in patients with active inflammatory bowel disease. Gut 2004, 53:685-693.
99. Ott J.M., Kuhbacher T., Musfeldt M., Rosensteil P., Hellmig S., Rehman A., Drew O., Weichert W., Timmis K.N., Schreiber S. Fungi and inflammatory bowel disease: Alterations of composition and diversity. Scand. J. Gastroenterol. 2008, 43:831-841.
100. Pei Z., Bibi E.J., Yang L., Zhou M., Francois F., Blaser M.J. Bacterial biota in the human distal oesophagus. Proc. Natl. Acad. Sci. USA 2004, 101:4250-4255.
101. Pitcher M.C.L., Beatty E.R., Cummings J.H. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 2000, 46:64-72.
102. Poxton I.R., Brown R., Sawyer A., Ferguson A. Mucosa-associated flora of the human colon. J. Med. Microbiol. 1997, 46:85-91.
103. Pullan R.D., Thomas G.A., Rhodes M., Newcombe R.G., Williams G.T., Allen A., Rhodes J. Thickness of adherent mucus gel on colonic mucosa and relevance to colitis. Gut 1994, 35:353-359.
104. Quigley M.E., Kelly S.M. Structure, function and metabolism of host mucus glycoproteins. Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology 1995, 175-199. CRC Press, Boca Raton, FL. G.R. Gibson, G.T. Macfarlane (Eds.).
105. Rajilic-Stojanovic M., Smidt H., De Vos W.M. Diversity of the human gastrointestinal tract microbiota revisited. Environ. Microbiol. 2007, 9:2125-2136.
106. Ramirez-Farias C., Slezak K., Fuller Z., Duncan A., Holtrop G., Louis P. Effect of inulin on the human gut microbiota: Stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 2009, 101:541-550.
107. Rinkinen M., Westermarck E., Salminen S., Ouwehand A.C. Absence of host specificity for in vitro adhesion of probiotic lactic acid bacteria to intestinal mucin. Vet. Microbiol. 2003, 97:55-61.
108. Rolhion N., Darfeuille-Michaud A. Adherent-invasive (Escherichia coli) in inflammatory bowel disease. Inflamm. Bowel Dis. 2007, 13:1277-1283.
109. Ruas-Madiedo P., Gueimonde M., Fernandez-Garcia M., de los Reyes-Gavilan C., Margolles A. Mucin degradation by a Bifidobacterium strain isolated from the human intestinal microbiota. Appl. Environ. Microbiol. 2008, 74:1936-1940.
110. Saitoh S., Noda S., Aiba Y., Takagi A., Sakamoto M., Benno Y., Koga Y. Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel disease. Clin. Diagn. Lab. Immunol. 2002, 9:54-59.
111. Sasaki M., Sitaraman S.V., Babbin B.A., Gerner-Smidt P., Ribot E.M., Garrett N., Alpern J.A., Akyildiz A., Theiss A.L., Nusrat A., Klapproth J.M. Invasive Escherichia coli are a feature of Crohn's disease. Lab. Invest. 2007, 87:1042-1054.
112. Satsangi J., Landers C.J., Welsh K.I., Koss K., Targan S.R., Jewell D.P. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflamm. Bowel Dis. 1998, 4:18-26.
113. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 1977, 31:107-133.
114. Schultsz C., Moussa M., van Ketel R., Tytgat G.N., Dankert J. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J. Clin. Pathol. 1997, 50:573-579.
115. Schultsz C., van den Berg F.M., Ten Kate F.W., Tytgat G.N.J., Dankert J. The intestinal mucosal layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 1999, 117:1089-1097.
116. Sepehri S., Kotlowski R., Bernstein C.N., Krause D.O. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm. Bowel Dis. 2007, 13:675-683.
117. Simon G.L., Gorbach S.L. The human intestinal microbiota. Dig. Dis. Sci. 1986, 31:147S-162S.
118. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.J., Blugeon S., Bridonneau C., Furet J.P., Corthier G., Grangette C., Vasquez N., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 2008, 105:16731-16736.
119. Sokol H., Seksik P., Furet J.P., Firmesse O., Nion-Larmurier I., Beaugerie L., Cosnes J., Corthier G., Marteau P., Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 2009, 15:1183-1189.
120. Steed H., Macfarlane G.T., Macfarlane S. Prebiotics, synbiotics and inflammatory bowel disease. Mol. Nutr. Food Res. 2008, 52:898-905.
121. Suau A., Bonnet R., Sutren M., Godon J.J., Gibson G.R., Collins M.D., Dore J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 1999, 65:4799-4807.
122. Subramanian S., Rhodes J.M., Hart C.A., Tam B., Roberts C.L., Smith S.L., Corkhill J.E., Winstanley C., Virji M., Campbell B.J. Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine. Inflamm. Bowel Dis. 2008, 14:162-175.
123. Swidsinski A., Weber J., Loening-Baucke V., Hale L.P., Lochs H. Spatial organisation and composition of the mucosal flora in patients with inflammatory bowel disease. J. Clin. Microbiol. 2005, 43:3380-3389.
124. Swidsinski A., Loening-Baucke V., Bengmark S., Scholze J., Doerrfel Y. Bacterial biofilm suppression with antibiotics for ulcerative and indeterminate colitis: Consequences of aggressive treatment. Arch. Med. Res. 2008, 39:198-204.
125. Turroni F., Ribbera A., Foroni D., van Sinderen D., Ventura M. Human gut microbiota and bifidobacteria: From composition to functionality. Antonie Van Leeuwenhoek 2008, 94:35-50.
126. Turroni F., Foroni E., Pizzetti P., Giubellini V., Ribbera A., Merusi P., Cagnasso P., Bizzarri B., de Angelis G.L., Shanahan F., van Sinderen D., Ventura M. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl. Environ. Microbiol. 2009, 75:1534-1545.
127. Tvede M., Bondesen S., Nielsen O.H., Rasmussen S.N. Serum antibodies to Bacteroides species in chronic inflammatory bowel disease. Scand. J. Gastroenterol. 1983, 18:783-789.
128. Van den Abbeele P., Grrtaert C., Possemiers S., Verstraete W., Verbeken K., van de Ewiele T. In vitro model to study the modulation of the mucin-adhered bacterial community. Appl. Microbiol. Biotech. 2009, 83:349-359.
129. Van der Waaij L.A., Harmsen H.J., Madjipour M., Kroese F.G., Zwiers M., van Dullemen H.M., de Boer N.K., Welling G.W., Jansen P.L. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: Commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm. Bowel Dis. 2005, 11:865-871.
130. Van Immerseel F., Ducatelle R., De Vos M., Boon N., Van De Viele T., Verbeke K., Rutgeerts P., Sas B., Louis P., Flint H.J. Buytyrate acid-producing bacteria as a novel probiotic treatment for inflammatory bowel disease. J. Med. Microbiol. 2010, 59:141-143.
131. Vasquez N., Mangin I., Lepage P., Seksik P., Doung J.P., Blum S., Schiffrin E., Suau A., Allez M., Vernier G., Treton X., Dore J., et al. Patchy distrubution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: A study using fluorescence in situ hybridisation and temperature gradient gel electrophoresis. Inflamm. Bowel Dis. 2007, 13:684-692.
132. Walmsley R.S., Anthony A., Sim R., Pounder R.E., Wakefield A.J. Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J. Clin. Pathol. 1998, 51:657-661.
133. Wang X., Heazlewood S.P., Krause D.O., Florin T.H. Molecular characterization of microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J. Appl. Microbiol. 2003, 95:508-520.
134. Wang M., Ahrne S., Jeppson B., Molin G. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol. Ecol. 2005, 62:1242-1247.
135. Whitehead R. Ulcerative colitis. Gastrointestinal and Oesophageal Pathology 1995, 622-632. Churchill Livingstone, Edinburgh, UK. 2nd edn. R. Whitehead (Ed.).
136. Willing B., Halfvarson J., Dicksved J., Rosenquist M., Jarnerot G., Engstrand L., Tysk C., Jansson J.K. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 2009, 15:653-660.
137. Wilson K.H., Blitchington R.B. Human colonic biota studied by ribosomal DNA sequence analysis. Appl. Environ. Microbiol. 1996, 62:2273-2278.
138. Yang F., Wang J., Li X., Ying T., Qiao S., Li D., Wu G. 2-DE and MS analysis of interactions between Lactobacillus fermentus 15007 and intestinal epithelial cells. Electrophoresis 2007, 28:4330-4339.
139. Yang L., Lu X., Nossa C.W., Francois F., Peek R.M., Pei Z. Inflammation and intestinal metaplasia of the distal oesophagus are associated with alterations in the microbiome. Gastroenterology 2009, 137:588-597.
140. Zhang M., Liu B., Zhang Y., Wei H., Lei Y., Zhao L. Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis. J. Clin. Microbiol. 2007, 45:496-500.
141. Zinkevich V., Beech I.B. Screening of sulfate-reducing bacteria in colonoscopy samples from healthy and colitic gut mucosa. FEMS Microbiol. Ecol. 2000, 34:147-155.
142. Zoetendal E.G., Von Wright A., Vilpponen-Salmela T., Ben-Amor K., Akkermans A.D., de Vos W.M. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 2002, 68:3401-3407.